Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

NO_LONGER_AVAILABLE

Conditions studied: Hypertension, Pulmonary

In brief

The aim of the study is to assess safety, tolerability and clinical effects of different doses of riociguat in patients with inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and who are not satisfactorily treated and cannot participate in any other CTEPH trial. In the US the study runs as an Expanded Access program under 21 CFR 312.320.

Key facts

Study ID

NCT01784562

Run by

Bayer

Last updated by the study team

2016-01-06

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female patients with CTEPH either inoperable or with persistent or recurrent PH after surgery

You may not qualify if…

• All types of pulmonary hypertension other than Dana Point Classification Group 4
• Operable patients listed for PEA (Pulmonary Endarterectomy)

Where it is running

• Study site — La Jolla, California, United States
• Study site — Los Angeles, California, United States
• Study site — Sacramento, California, United States
• Study site — Aurora, Colorado, United States
• Study site — Weston, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Iowa City, Iowa, United States
• Study site — Baltimore, Maryland, United States
• Study site — Boston, Massachusetts, United States
• Study site — Boston, Massachusetts, United States
• Study site — Ann Arbor, Michigan, United States
• Study site — Omaha, Nebraska, United States
• Study site — Newark, New Jersey, United States
• Study site — New York, New York, United States
• Study site — Cleveland, Ohio, United States
• Study site — Columbus, Ohio, United States
• Study site — Fairfield, Ohio, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Pittsburgh, Pennsylvania, United States
• Study site — Providence, Rhode Island, United States
• Study site — Dallas, Texas, United States
• Study site — El Paso, Texas, United States
• Study site — Houston, Texas, United States
• Study site — Vienna, State of Vienna, Austria
• Study site — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.